Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278K Hold
25,000
﹤0.01% 803
2025
Q4
$410K Sell
25,000
-30,000
-55% -$467K ﹤0.01% 621
2025
Q3
$736K Buy
+55,000
New +$650K 0.01% 413

Other funds holding PATH

Marex Group's PATH Position: Q1 2026 in Review

Marex Group reduced its UiPath (PATH) stake by 51% in Q1 2026, selling an estimated $336K and leaving 25,556 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

Marex Group first reported a position in PATH in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.2M in Q1 2024. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • Marex Group held 25,556 shares of UiPath worth $284K as of Q1 2026.
  • Marex Group sold 26,381 UiPath shares in Q1 2026, an estimated $336K.
  • UiPath made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #798 holding.
  • Marex Group first reported a position in UiPath in Q4 2023 and has held it in 10 quarters since.
  • Marex Group's UiPath position peaked at $1.2M in Q1 2024.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.